Contact
Positions
Professor
- Organization:
- West Virginia University School of Medicine
- Department:
- Ophthalmology and Visual Sciences
- Classification:
- Faculty
Professor & Chairman
- Organization:
- West Virginia University School of Medicine
- Department:
- Biochemistry
- Classification:
- Faculty
Education
- PhD, Wesleyan University, 1998
Publications
[2020]
- Sundar J., Matalkah F., Jeong B., Stoilov P., Ramamurthy V,
The Musashi proteins MSI1 and MSI2 are required for photoreceptor morphogenesis and vision in mice, Journal of Biological Chemistry, Volume 296, 2020 - Salido EM, Ramamurthy V. Proteoglycan IMPG2 Shapes the Interphotoreceptor Matrix and Modulates Vision. J Neurosci. 2020 May 13;40(20):4059-4072. doi: 10.1523/JNEUROSCI.2994-19.2020. Epub 2020 Apr 7.PMID: 32265257
[2019]
- Moye AR, Bedoni N, Cunningham JG, Sanzhaeva U, Tucker ES, Mathers P, Peter VG, Quinodoz M, Paris LP, Coutinho-Santos L, Camacho P, Purcell MG, Winkelmann AC, Foster JA, Pugacheva EN, Rivolta C, Ramamurthy V. Mutations in ARL2BP, a protein required for ciliary microtubule structure, cause syndromic male infertility in humans and mice. Plos Genetics. 2019 Aug;15(8):e1008315. DOI: 10.1371/journal.pgen.1008315. PMID: 31425546; PMCID: PMC6715254
- Grenell A, Wang Y, Yam M, Swarup A, Dilan TL, Hauer A, Linton JD, Philp NJ, Gregor E, Zhu S, Shi Q, Murphy J, Guan T, Lohner D, Kolandaivelu S, Ramamurthy V, Goldberg AFX, Hurley JB, Du J. Loss of MPC1 reprograms retinal metabolism to impair visual function. Proceedings of the National Academy of Sciences of the United States of America. 2019 Feb;116(9):3530-3535. DOI: 10.1073/pnas.1812941116. PMID: 30808746; PMCID: PMC6397593.
[2018]
- Dilan TL, Moye AR, Salido EM, Saravanan T, Kolandaivelu S, Goldberg AFX, Ramamurthy V. ARL13B, a Joubert Syndrome-Associated Protein, Is Critical for Retinogenesis and Elaboration of Mouse Photoreceptor Outer Segments. The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. 2019 Feb;39(8):1347-1364. DOI: 10.1523/jneurosci.1761-18.2018. PMID: 30573647; PMCID: PMC6381253.
- Wright ZC, Loskutov Y, Murphy D, Stoilov P, Pugacheva E, Goldberg AFX, Ramamurthy V. ADP-Ribosylation Factor-Like 2 (ARL2) regulates cilia stability and development of outer segments in rod photoreceptor neurons. Scientific Reports. 2018 Nov;8(1):16967. DOI: 10.1038/s41598-018-35395-3. PMID: 30446707; PMCID: PMC6240099.
- Deng WT, Kolandaivelu S, Dinculescu A, Li J, Zhu P, Chiodo VA, Ramamurthy V, Hauswirth WW. Cone Phosphodiesterase-6γ' Subunit Augments Cone PDE6 Holoenzyme Assembly and Stability in a Mouse Model Lacking Both Rod and Cone PDE6 Catalytic Subunits. Frontiers in Molecular Neuroscience. 2018 ;11:233. DOI: 10.3389/fnmol.2018.00233. PMID: 30038560; PMCID: PMC6046437.
-
Moye AR, Singh R, Kimler VA, Dilan TL, Munezero D, Saravanan T, Goldberg AFX, Ramamurthy V. ARL2BP, a protein linked to retinitis pigmentosa, is needed for normal photoreceptor cilia doublets and outer segment structure. Molecular Biology of the Cell. 2018 Jul;29(13):1590-1598. DOI: 10.1091/mbc.e18-01-0040. PMID: 29718757; PMCID: PMC6080659.
-
Dilan TL, Singh RK, Saravanan T, Moye A, Goldberg AFX, Stoilov P, Ramamurthy V. Bardet-Biedl syndrome-8 (BBS8) protein is crucial for the development of outer segments in photoreceptor neurons. Human Molecular Genetics. 2018 Jan;27(2):283-294. DOI: 10.1093/hmg/ddx399. PMID: 29126234; PMCID: PMC5886228.
Additional Info
The Ramamurthy lab aims to decipher the biochemical pathways that control the complex processing of information through neurons to the brain. We use the visual system as a model to comprehend this process. In vision, defects in light signal processing result in neuronal death and blindness. Several recent studies have established the link between mutations in various genes to blinding diseases. However, the functional role of these genes and why defects in these genes cause blindness remains elusive. In our research group, we use various molecular, biochemical and physiological approaches to probe the biochemical basis behind defects that cause the break down of the neuronal circuits and ultimately visual impairment. Our investigations are also critical in designing innovative therapeutic approaches in treating these neuronal degenerations.
Techniques Used in the Laboratory: Cloning, expression and purification of proteins in bacteria, insect and human cells; Creation of transgenic and knock out mouse models of disease; Analyses of protein complexes by immunoprecipitation, liquid chromatography and mass-spectrometry; protein localization by in-situs, confocal immunofluorscence and electron microscopy; Electrophysiology; Synthesis, folding and assembly of proteins studied by pulse-label, pulse-chase and immunoprecipitation; Protein structure-function relationship.
Keywords: Neuronal degeneration, Childhood Blindness, Congenital Stationary Night Blindness, Signal processing from retina to brain, Synaptic transmission, Ribbon Synpases, Visual cortex, Gene therapy, Small molecule therapy, Posttranslational modifcation of proteins and protein assembly
Research Interests
Protein trafficking in neurons
Proteins move at the rate of 1000 molecules per second in photoreceptor cells between different compartments. Defects in this process lead to blindness in humans. How do proteins move at this rapid rate? How are proteins retained in different compartments? We are currently testing our hypothesis that small GTPases play an important role in regulating protein trafficking between different regions of photoreceptor cells.
Protein assembly and function
How do multimeric proteins assemble? We use phosphodiesterase-6 as a model system to understand protein assembly. We believe protein-lipid modification contributes to this process and are currently testing this hypothesis.
Treatment(s) for neurodegenerative diseases
We used adeno-associated viral mediated gene therapy to restore vision in a mouse model for severe childhood blindness. We hope to expand this line of research using cutting-edge genome engineering methods such as TALENs and CRISPR system for stem cell therapy.
Small molecules, translational suppressors, treatment for blindness?
As an alternative to gene therapy, we are exploring the use of small molecule translational read-through suppressors to overcome non-sense mutations that lead to diseases. This project is in collaboration with Dr. Brian Popp in the Chemistry Department.
Splicing and blinding diseases
Defects in ubiquitously expressed splicing genes are a cause of retinitis pigmentosa (RP) in humans. In collaboration with Dr. Peter Stoilov at Biochemistry, we are identifying the mechanism behind splicing defects and blindness. The hope is to use the knowledge gained in this study to design novel treatments for patients with RP.
Grants and Research
This project will investigate how RNA binding proteins boost protein expression in photoreceptor cells to enable vision, an unexplored aspect of the photoreceptor cell biology. Our work will allow us to better understand how photoreceptors function and how blinding disease develops. We expect that the results of this study will open new ways to treat blinding diseases